AstraZeneca PLC

Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts

27 Dec 2024 02:32:04 By NASDAQ US Markets

AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan

24 Dec 2024 02:40:25 By NASDAQ US Markets

Is AstraZeneca Stock a Buy?

22 Dec 2024 06:16:51 By NASDAQ US Markets

3 Unstoppable Stocks to Buy Right Now

15 Dec 2024 06:33:05 By NASDAQ US Markets

March 2025 Options Now Available For AstraZeneca (AZN)

06 Dec 2024 11:01:12 By NASDAQ US Markets

AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer

05 Dec 2024 22:31:29 By NASDAQ US Markets

FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer

04 Dec 2024 21:59:20 By NASDAQ US Markets

AstraZeneca Names A MSK Leader To Global Cancer Post

25 Nov 2024 11:17:34 By Forbes - World

Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions

18 Nov 2024 13:17:39 By NASDAQ US Markets

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

14 Nov 2024 07:43:11 By NASDAQ US Markets

AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript

12 Nov 2024 17:04:51 By NASDAQ US Markets

AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance

12 Nov 2024 03:02:49 By NASDAQ US Markets

AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing

12 Nov 2024 03:02:49 By NASDAQ US Markets

AstraZeneca : Wainzua Recommended By CHMP For EU Approval In Hereditary Transthyretin Amyloidosis

21 Oct 2024 03:00:49 By NASDAQ US Markets

AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline

08 Oct 2024 14:20:34 By NASDAQ Stocks

Arcus Announces Clinical Trial Collaboration With AstraZeneca To Evaluate Casdatifan

02 Oct 2024 17:15:33 By NASDAQ US Markets

AstraZeneca Becomes Oversold (AZN)

24 Sep 2024 18:47:41 By NASDAQ US Markets

AstraZeneca Becomes Oversold (AZN)

24 Sep 2024 18:45:01 By NASDAQ Stocks

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

24 Sep 2024 13:14:18 By NASDAQ Stocks

AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance

23 Sep 2024 03:29:23 By NASDAQ US Markets